Introduction
The production of mature blood cells, hematopoiesis, occurs predominantly in the adult bone marrow. Dierentiation of a limited population of self-renewing pluripotent stem cells results in the generation of distinct lineage-committed myeloid or lymphoid progenitor cells (Ogawa, 1993) . These cells can then be further induced to dierentiate, in the case of myeloid progenitors, into granulocytes, monocytes, megakaryocytes and erythrocytes. A large family of hematopoietic cytokines are able to strictly control the proliferation, dierentiation, survival and eector functions of these myeloid progenitors. IL-3, for example, stimulates the growth of multipotential progenitor cells that will eventually dierentiate into granulocytes, macrophages, megakaryocytes and erythrocytes. This ability to stimulate proliferation works primarily during early hematopoiesis without specifying the ®nal dierentiation fate of the progenitor. Other cytokines act at a later stage to direct the dierentiation process towards speci®c myeloid cells. For example, IL-5 is critical for the terminal dierentiation of myeloid progenitors to eosinophils, while erythropoietin (EPO) stimulates dierentiation of erythroid lineages. In a similar fashion, granulocyte colony stimulating factor (G-CSF) plays a critical role in granulopoiesis resulting in the production of neutrophils. The critical role of these cytokines in hematopoiesis is highlighted by gene knockout studies. G-CSF-de®cient mice, for example, develop chronic neutropenia and have a greatly impaired response to infection (Lieschke et al., 1994) . These late-acting cytokines initially stimulate cellular proliferation followed by dierentiation to a non-proliferating mature cell. It is the combinations of cytokines acting on a myeloid progenitor that will initiate a speci®c developmental program determining the ®nal dierentiation fate of the target cell.
Hematopoietic cytokines act on speci®c cell surface receptors resulting in the initiation of intracellular signal transduction events (reviewed in Smithgall, 1998) . The ®rst step in this process usually commences with receptor dimerization upon ligand binding. Cytokine receptors lack an intrinsic kinase-domain and instead bind to members of the Janus Kinase (JAK) family of tyrosine kinases (Liu et al., 1998) . Receptor dimerization results in JAK activation through cross-phosphorylation followed by tyrosine phosphorylation of speci®c residues present on the intracellular domains of cytokine receptor sub-units. This results in the recruitment of SH2-domain containing signaling molecules which include members of the STAT family of transcription factors. The mechanisms of activation and recruitment of STATs is the subject of many of the reviews in this issue and will not be discussed here in detail.
The role of STATs in in¯uencing the proliferation, dierentiation and survival status of hematopoietic progenitors has been the subject of extensive research over the last few years. This work has initially focused on identifying the STAT isoforms activated by speci®c cytokines, their role in the regulation of target genes and has recently been followed up by analysis of STAT nullmutant mice to de®ne the critical players in hematopoietic dierentiation and immune function. The ®rst part of this review will focus on the current understanding of the role of STATs in myeloid dierentiation. The second section discusses how deregulated STAT activation is involved in the disruption of the normal process of myeloid dierentiation resulting in uncontrolled proliferation, a block in dierentiation and the development of myeloid leukemia.
STATs and myeloid dierentiation
In vitro studies
The availability of various myeloid cell lines has allowed analysis of the potential role of STATs in proliferation, dierentiation and survival in vitro. The ability to activate or inhibit transcription through overexpression of mutant STATs has provided evidence for a role for this family of transcription factors in hematopoiesis. Myeloid leukemia cells are blocked at an early stage of dierentiation and proliferate aberrantly. In culture, these cells can be induced to dierentiate terminally by a variety of agents and cytokines providing a good model system for investigating dierentiation. An essential role for STAT3 in IL-6 induced macrophage dierentiation of myeloid M1 cells was ®rst suggested by the inability of IL-6R mutants lacking the STAT3 binding motif to generate growth arrest and dierentiation (Figure 1) . A critical role for STAT3 was further investigated through the use of a dominant-negative STAT3 mutant (STAT3DN). In M1 cells, overexpression of STAT3DN abolished the dierentiation of these cells in response to IL-6 and LIF Minami et al., 1996) . As mentioned above, IL-6 exposure normally leads to morphological changes and induction of speci®c gene expression characteristic of terminally dierentiated macrophages. In M1 STAT3DN-transformants these changes did not occur suggesting a block in macrophage dierentiation. This dierentiation is accompanied by a gradual inhibition of cell growth which again was not observed in the STAT3DN cell lines. Two genes known to be important for this IL-6 induced growth arrest and induction of dierentiation are c-myc and c-myb (Homan-Liebermann and Liebermann, 1991) . Indeed STAT3DN inhibited the normal IL-6 induced repression of c-myc and c-myb suggesting that these two genes may be bona ®de targets of STATs regulating hematopoietic proliferation versus dierentiation. Interestingly, the presence of dominant-negative STAT3 converted the action of IL-6 from a dierentiation to proliferative agent suggesting that IL-6 generates antagonistic signals in which STAT3 is critical in determining whether cells dierentiate or proliferate in response to cytokine challenge. In another study using a mouse myeloid cell line, LGM-1, exogenously expressing the G-CSF receptor (G-CSFR), STAT3 was implicated in neutrophil dierentiation (Shimozaki et al., 1997) . Addition of G-CSF to the G-CSFR cells resulted in a block in proliferation, down-regulation of c-myc and dierentiation into cells with lobulated nuclei. Introduction of a dominant-negative STAT3 prevented both the growth arrest and morphological changes observed by G-CSF treatment.
Erythropoietin (EPO) plays an important role in the proliferation and dierentiation of erythroid progenitors. EPO has been found to induce the phosphorylation and activation of STAT5 but not STAT1a or STAT3 in the UT-7 subline UT-7/GM (Kirito et al., 1997) . In these cells EPO treatment also stimulates erythroid dierentiation. Interestingly, treatment of UT-7/GM with GM-CSF activates both STAT1a and STAT3 and inhibits EPO-induced erythropoiesis. Overexpression of STAT1a or STAT3 also suppressed EPOinduced dierentiation, while dominant-negative forms of these two STATs prevented the inhibitory eect of GM-CSF on erythropoiesis (Kirito et al., 1998) . This inhibitory eect of STAT1a on dierentiation appears to be related to the regulation of cell cycle progression, a process thought to be critical for development of erythroid progenitors (Carroll et al., 1995) . It has also been demonstrated that a dominant-negative STAT3 induced morphological dierentiation of embryonic stem cells (Boeuf et al., 1997) . These data are in contrast to the STAT3 induced dierentiation of M1 cells to macrophages discussed above . Thus the ability of a speci®c STAT to induce or inhibit the process of myelopoiesis appears to be cell type speci®c. In a similar study utilizing the erythroleukemic cell line TF-1, STAT5 has been implicated in erythropoietin-induced proliferation (Chretien et al., 1996) . TF-1 cells express a truncated EPO-receptor (EpoR) that is defective in STAT5 activation and induces erythroid dierentiation rather than proliferation. Transduction of a wild-type receptor into TF-1 cells restores the ability of EPO to activate STAT5 and results in proliferation rather than dierentiation. These data suggest that EPO-induced dierentiation correlates with impaired EPO-induced STAT5 activation. In contrast, utilizing EpoR mutants, Iwatsuki et al. (1997) found that the activation of STAT5 leads to erythroid dierentiation in the murine ELM-I-1 erythroleukemia cell line. Furthermore, overexpression of a dominant-negative STAT5 suppressed EPOdependent erythroid dierentiation. These discrepancies may be due to dierences in cell lines and highlight the problems of an in vitro, cell line-based analysis of STAT function, where cells may be lacking other critical components of the dierentiation process. Indeed, the expression of mutant EpoRs into fetal liver cells derived from EpoR (7/7) mice has revealed that the receptor that best reconstitutes erythropoiesis does not correlate with the ability to activate STAT5 but rather the phosphatidylinositol lipid kinase, PI3K (Klingmuller et al., 1997) .
The role of STAT5 during the dierentiation of myelomonocytic cells has been investigated using both the U937 promonocytic cell line and promyelocytic HL-60 cells (Woldman et al., 1997) . STAT5 was found to be activated by several inducers of monocytic and granulocytic dierentiation. Myelomonocytic growth Figure 1 Schematic representation of the role of STAT3 and STAT5 in`in vitro' myeloid dierentiation. Cytokines important for the dierent lineages, the STATs activated by these cytokines and potentially important target genes are indicated
The role of STATs in myeloid differentiation and leukemia P Coffer et al factor (cMGF) induced proliferation and dierentiation of chicken myeloid progenitor cells was also analysed. Addition of cMGF resulted in the rapid activation of STAT5 and the onset of myelomonocytic dierentiation. These data hint at a role for STAT5 in the functional changes accompanying the maturation of myeloid progenitor cells to a terminally dierentiated stage. A role for STAT5 in regulating proliferation is further supported by studies in which a dominant-negative STAT5 partially inhibited growth of an IL-3 dependent cell line (Mui et al., 1996) . Expression of a dominant-negative STAT5A in the murine myeloid cytokine-dependent line, 32D, inhibited both IL-3 dependent proliferation and G-CSF dependent dierentiation without the induction of apoptosis (Ilaria et al., 1999) . Importantly, expression of this interfering mutant in primary murine bone marrow inhibited G-CSF dependent granulocyte colony formation in vitro. Thrombopoietin (TPO) is the major regulator of megakaryocyte dierentiation and platelet production acting through the TPO-receptor, c-mpl. A 10aa intracellular deletion of c-mpl was found to completely abrogate STAT activation while permitting proliferation and survival of transfected cell lines (Dorsch et al., 1997) . The ability of TPO to induce megakaryocytic dierentiation of UT-7 cells expressing wild-type (cmpl) or mutant (c-mplD10) receptors was recently analysed (Dorsch et al., 1999) . Whereas TPO-treated cells expressing c-mpl show a striking increase in size, adherence and expression of the megakaryocytic marker CD41a, c-mplD10 UT-7 cells remained morphologically unchanged. In the CMK megakaryoblastic leukemia cell line, TPO treatment results in megakaryocytic dierentiation and induction of the cell cycle inhibitor p21 CIP . Ectopic expression of p21 CIP is in itself sucient to induce dierentiation (Matsumura et al., 1997) and STAT5 was found to be able to interact with oligonucleotide probes corresponding to STAT-binding sites within the p21 CIP promoter. This suggests that a possible mechanism by which TPO can induce megakaryocytic dierentiation is through STAT5-dependent induction of p21 CIP resulting in cell cycle inhibition and induction of a speci®c developmental program.
The contradictory results often observed between cell lines utilizing ectopic overexpression of wild-type or dominant-negative STAT proteins may be explained by considering a role for the`level' of activation governing a speci®c response. In this model, high-level activation may in fact be inhibitory by the induction of`aspeci®c' genes not normally associated with activation of endogenous STAT proteins . This is demonstrated by the low level of STAT5 activation and induction of dierentiation observed when TF1 cells are treated with EPO due to the expression of a mutant receptor (Chretien et al., 1996) . However, as mentioned above, introduction of a wild-type receptor results in high-level STAT5 activation and stimulates proliferation rather than dierentiation. This may also explain the ability of IL-3 to inhibit EPO-dependent dierentiation in transfected BaF3 cells since in this system IL-3 is a potent STAT5 activator, while EPO is a weak STAT5 activator (Krosl et al., 1996) . The concept of activation levels as being important for the regulation of a dierentiation outcome has been demonstrated for other transcription factor families. It is also likely that the interplay between STATs and their regulators e.g. CIS, PIAS will govern the strength of a cytokine-induced transcriptional response de®ning the decision to proliferate or dierentiate.
Specificity in STAT function
With four JAK kinases and six STAT proteins there seems to be a limited speci®city in this signaling pathway. However, speci®city can be enhanced by several dierent mechanisms. Firstly, upon cytokine stimulation the activated STAT transcription factors are present both as homo-dimers and hetero-dimers (Leonard and O'Shea, 1998) . Secondly, dierent STAT binding sequences have dierent anities for the dierent homo-and hetero-dimers Seidel et al., 1995) . Thirdly, besides tyrosine phosphorylation, serine phosphorylation of the STAT proteins seems to be essential for STATs to trans-activate target genes (Wen et al., 1995; Yamashita et al., 1998) . Although the precise kinases involved in serine phosphorylation of all the dierent STATs have yet to be de®ned it is very likely that ®ne-tuning of the response can take place via controlled activation of these kinases.
Interestingly, the cellular context of dierent cytokine receptors seems to be involved in determining the usage of the dierent STAT proteins. A clear example for this level of control is found in neutrophils. The IFNgR activates STAT3 in this cell type (Caldenhoven et al., 1999b) , whereas this receptor only activates STAT1 in human eosinophils (van der Bruggen et al., 1995) . In addition, GM-CSF can activate STAT1 in eosinophils (van der Bruggen et al., 1995) , whereas the GM-CSFR does not engage STAT1 in normal human neutrophils (Al-Shami et al., 1998) . This remarkable level of control of the pathway is not caused by the mere availability of the dierent STAT proteins, because in both neutrophils and eosinophils sucient amounts of the STAT1 and STAT3 proteins are present. Currently no data are available to explain these phenomena, but these ®ndings clearly point to the importance of the relevant cellular context.
Differential splicing, protein processing and functional diversity
As described above, STAT3 activation by G-CSF is implicated in neutrophilic dierentiation (Shimozaki et al., 1997; Chakraborty and Tweardy, 1998a,b; Ward et al., 1999a,b) . A more detailed examination of STAT3 activation by G-CSF showed that multiple isoforms of STAT3 are activated by G-CSF. Three distinct isoforms of STAT3 have been described, that all arise from a single gene (Figure 2 ). STAT3b, an alternatively spliced form of STAT3a (full length STAT3), lacks the c-terminal 55 amino acids (Schaefer et al., 1995; Caldenhoven et al., 1996) . In addition, a 72 kDa STAT3g protein was described that is also truncated at its c-terminus and is derived from STAT3a by limited proteolysis (Chakraborty and Tweardy, 1998a) . In immature human myeloid cells capable of dierentiation into neutrophils in response to G-CSF, STAT3b is the predominant isoform activated by G-CSF (Chakraborty et al., 1996) . Interestingly, in leukemic
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The role of STATs in myeloid differentiation and leukemia P Coffer et al cells which are refractory to G-CSF induced dierentiation, both STAT3a and STAT3b are activated. Overexpression of STAT3a even renders cells partially resistant to G-CSF induced dierentiation (Chakraborty et al., 1999) . By contrast, in terminally dierentiated neutrophils, STAT3g is activated by G-CSF (Chakraborty and Tweardy, 1998a) . Finally, there is a marked change in STAT3 isoform expression during the myeloid dierentiation of normal human CD34+ cells (Biethahn et al., 1999) . STAT3b is functionally distinct from STAT3a and behaves as a dominant negative repressor in some, but not all cell types (Schaefer et al., 1997; Sasse et al., 1997; Caldenhoven et al., 1996) . Together with the ®nding that STAT3a activation is closely linked with the regulation of proliferation, these ®ndings suggest that composition of the STAT3 dimer is relevant for the decision between proliferation and dierentiation. STAT3b containing dimers might well regulate dierentiation-related genes, while STAT3a containing dimers are likely to induce genes that are part of the G-CSF-induced proliferation program (Chakraborty and Tweardy, 1998b) .
For STAT5, the situation is even more complex. STAT5A and STAT5B are encoded by two distinct genes, that clearly have both distinct as well as overlapping functions (Udy et al., 1997; Liu et al., 1997; Teglund et al., 1998) . Splicing variants of STAT5A (STAT5A1 and A2) and STAT5B (STAT5Bd40C) have been cloned from rat mammary gland and liver, but the functional signi®cance of these isoforms has not been addressed yet (Ripperger et al., 1995; Kazansky et al., 1995) . The ®rst suggestion that dierent STAT5 isoforms contribute to IL-3 mediated signaling in myeloid cells was made by Azam et al. (1995) . In mature murine myeloid cell lines, IL-3 activates STAT5A and STAT5B (Azam et al., 1995) . By contrast, in more immature murine myeloid cell lines, IL-3 activates c-terminally truncated forms of STAT5A (p77) and STAT5B (p80) (Figure 2 ). Similar activation of p77 and p80 was also observed with IL-2 and EPO in murine cell lines .
Moreover, p77 and p80 expression was also observed in immature mouse macrophages, while full-length STAT5 was more predominant in mature macrophages (Lokuta et al., 1998) . However, although peritoneal macrophages express far more full length STAT5 than p77/p80, GM-CSF only activates p77/p80 in these cells (Welte et al., 1997) . These c-terminally truncated p77 and p80 appear to have distinct properties compared to full length STAT5. In transient transfection experiments, they fail to support prolactin-induced activation of the b-casein promoter, but rather act as dominant negative regulators of transcription (Moriggl et al., 1996) . Similarly, overexpression of synthetic p77 or p80 in 32D or BaF3 cells blocks the IL-3 induced expression of STAT5 dependent genes, such as CIS and OSM Mui et al., 1996) . The same phenomenon is observed when IL-3 induced gene expression is compared between immature and mature murine hematopoietic cells (Azam et al., 1997) . In murine cells, p77 and p80 do not result from alternative splicing, but are generated by protein processing. STAT5 is processed by a nuclear serine endopeptidase which is expressed in early murine myeloid, but not lymphoid progenitor cell lines (Azam et al., 1997; Meyer et al., 1998; Lee et al., 1999) . This protease cleaves STAT5A and 5B in a perfectly conserved c-terminal motif ATY*MDQA. When this motif was mutated, STAT5 becomes resistant to proteolytic cleavage (Lee et al., 1999) . In a preliminary characterization, cleavage-resistant STAT5B partially induced dierentiation of murine FDC-P1, while wildtype STAT5 supported proliferation and self-renewal of these cells. These observations clearly demonstrate that dierent STAT5 isoforms are likely to perform dierent functions in immature and mature murine cells.
In freshly isolated human monocytes, a p80 STAT isoform was activated by GM-CSF (Rosen et al., 1996) . However, since this p80 reacts with antibodies directed to the c-terminus of STAT5, this p80 protein is likely to dier from the p80 observed in early murine myeloid cells. A c-terminally truncated p80 STAT5 was found to be activated by IL-5 and GM-CSF in freshly activated human eosinophils and neutrophils (Caldenhoven et al., 1999a) . Activation of full length STAT5 by GM-CSF in human neutrophils was also reported, but due to the use of c-terminal antibodies p80 activation might have been missed (Al-Shami et al., 1998) . Surprisingly, expression as well as GM-CSF/IL-5 induced activation of this p80 STAT5 protein is enhanced during dierentiation of human primary CD34+ stem cells into eosinophils and neutrophils . p80 containing STAT5 complexes are able to bind to elements which STAT5A or 5B dimers are unable to bind, such as the IRE from the ICAM-1 promoter . This should greatly enhance the spectrum of genes that can be regulated by GM-CSF in these cells. Although further experiments are needed to explain the dierent regulation of p80 during human versus mouse myeloid dierentiation, these data strongly suggest that dierential usage of STAT5 isoforms generated by protein processing or RNA splicing is likely to contribute to the regulation of STAT5-dependent gene expression in myeloid cells. The role of STATs in myeloid differentiation and leukemia P Coffer et al
Hematopoeisis in STAT null-mutant mice
Recently the physiological role of each individual STAT protein has been examined through the analysis of STAT`knockout' mice harboring a null allele for the particular gene. Interestingly, the generation of several STAT (7/7) mice has revealed a surprising speci®city in the role of members of this transcription factor family in hematopoietic development and function. While STAT1 has been shown to be activated by a variety of cytokines and growth factors, the generation of STAT1 (7/7) mice demonstrated selective defects in their response to interferons (Durbin et al., 1996; Meraz et al., 1996) . Mice were highly susceptible to opportunistic infections and extraordinarily sensitive to viral pathogens. They exhibited normal lymphoid and myeloid development suggesting that STAT1 does not play a critical role in hematopoiesis but rather is necessary for induction of genes required for normal host defence. STAT4 has been reported to be fairly widely expressed including during early myeloid dierentiation (Yamamoto et al., 1994) . However, it appears to be exclusively activated by IL-12 and indeed in STAT4 (7/7) mice the major IL-12 mediated functions are perturbed (Kaplan et al., 1996a; Thierfelder et al., 1996) . These include IFNg production, cellular proliferation, enhancement of natural killer cell cytotoxicity and Th1 cell dierentiation. The mice were viable, fertile and had no defects in hematopoiesis suggesting that the developmentally regulated myeloid expression ful®ls a redundant, non-essential function. In a similar fashion, STAT6 (7/7) mice have defects in IL-4 mediated functions including immunoglobulin class switching, T-cell proliferation and Th2 dierentiation demonstrating the essential role of STAT6 in IL-4 signaling (Shimoda et al., 1996; Takeda et al., 1996; Kaplan et al., 1996b) . Again, the lack of eects of STAT6 deletion on the development of granulocytes, monocytes and erythrocytes argues against a role for this transcription factor in regulating myeloid dierentiation.
STAT3 has been demonstrated to be activated by a variety of cytokine receptors including G-CSF and members of the IL-3/IL-5/GM-CSF family (reviewed in Chakraborty and Tweardy, 1998b; de Groot et al., 1998) . STAT3-de®cient mice were found to die early in embryogenesis prior to gastrulation (Takeda et al., 1997) . Since STAT3 mRNA is expressed in the extraembryonic visceral endoderm, the principle site of nutrient exchange, it is thought that lethality may be due to nutritional insuciency. An elegant investigation of STAT3 function was performed by Takeda et al. (1999) who generated mice with a cell type-speci®c disruption of STAT3 in macrophages and neutrophils utilizing the Cre-loxP recombination system. These mice have allowed an analysis of the role of a speci®c STAT in the eector functions of speci®c subsets of myeloid cells. The mutant mice were highly susceptible to endotoxin shock with increased production of in¯ammatory cytokines such as TNFa, IL-1 and IFNg. Production of these cytokines from STAT3-de®cient macrophages is dramatically augmented in response to lipopolysaccharide. Furthermore, the suppressive effects of IL-10 on macrophages and neutrophil cytokine production was completely abolished. These results indicate that STAT3 plays a critical role in controlling the anti-in¯ammatory response of certain myeloid cells although it doesn't provide answers as to the role of this STAT in myeloid dierentiation.
While STAT5 was initially identi®ed in mammary gland tissue as a prolactin-induced transcription factor, it has subsequently been found to be activated by a plethora of cytokines, growth factors and hormones. STAT5 is encoded by two highly related genes whose proteins, STAT5a and STAT5b, are 96% homologous (Liu et al., 1995) . There are subtle dierences in tissue expression of these two isoforms and they also exhibit distinct DNA-binding speci®cities. STAT5a knockout mice developed normally but female mice failed to lactate after parturition due to a lack of mammary gland terminal dierentiation . These mice have been further analysed to study the eects of STAT5a deletion on the activation of myeloid cells by GM-CSF (Feldman et al., 1997) . STAT5a null mice had normal numbers of nucleated cells from bone marrow (BM) suggesting no speci®c defects in myeloid development. BM culture-derived macrophages were found to be de®cient in the GM-CSF induced expression of the CIS and the bcl-2 like A1 gene which are thought to be important for regulating cellular growth, survival and dierentiation. Analysis of the proliferative responses of BM-derived macrophages revealed no dierences between wild-type and null-mutant mice at low concentrations of GM-CSF (50.3 ng/ml). However, at higher GM-CSF concentrations (40.5 ng/ml), there was a signi®cant decrease in growth in STAT5a (7/7) mice. A more recent study has analysed the eect of deleting STAT5a and STAT5b either individually or simultaneously (Teglund et al., 1998) . The STAT5a/b (7/7) mice were much smaller than their wild-type littermates probably due to signi®cant defects in growth hormone function. In addition, the STAT5a/b double mutant female mice were found to be infertile, unlike the single allele deletions. This correlated with a lack of p27 KIP1 expression in the ovaries of these animals, a gene previously shown to be required for ovarian function. There were no signi®cant dierences in the number of red cells, hemoglobin levels or numbers of platelets between the various mice. The lack of any eect on erythroid development is in contrast to studies that have implicated STAT5 in erythropoiesis (Damen et al., 1995; Iwatsuki et al., 1997) . By contrast, Socolovsky et al. (1999) have shown that STAT5a/b (7/7) mice suer from fetal anemia and apoptosis of red cell progenitors. This is likely to be caused by a defect in Epo-induced expression of the anti-apoptotic Bcl-xL gene. The normal steady-state adult hematocrit observed in adult mutant mice might be caused by compensatory mechanisms, such as the extramedullary expansion of erythroid tissue (Morrigl et al., 1999) or upregulation of STAT1 or STAT3 (Teglund et al., 1998) .
In STAT5a/b (7/7) mice but not STAT5a or STAT5b knockouts, there was a decrease in the white cell count that was associated with a decrease in lymphocytes. Conversely there was an increased percentage of neutrophils. Bone marrow hematopoietic progenitor colony assays revealed no dierence in erythroid colony forming units in concurrence with the normal number of erythrocytes observed in the peripheral blood. However, there was a reduction in the number of colonies induced in response to IL-3, IL-5, GM-CSF or G-CSF and the colonies were smaller. While this implicates STAT5 in mediating IL-3/IL-5/GM-CSF mediated regulation of proliferation it does not seem to play a major role in dierentiation as such.
The data obtained from knockout mice has demonstrated surprisingly speci®c roles for the various STAT transcription factors in vivo despite redundancy in their activation pro®les by cytokines in vitro. These data challenge many of the in vitro studies discussed above which have implicated STATs in myeloid dierentiation. It will require further work analysing combinations of STAT null-mutants to determine whether there may be functional redundancy in the knockout mice masking an important role for STATs in myeloid hematopoiesis.
STAT target genes in myeloid differentiation and function
Several STAT target genes have been identi®ed that play a role in regulating proliferation and these have been discussed brie¯y in previous sections of this review. As previously discussed, these genes are likely to play a critical role in deciding the balance between proliferation and dierentiation thereby regulating myeloid cell fate decisions. This is discussed here further. One of the ®rst STAT target genes to be identi®ed was the cytokine-inducible SH2-containing protein (CIS), subsequently found to be part of a large family of regulatory molecules (Yoshimura, 1998). CIS was found to be induced by a wide variety of cytokines including GM-CSF, IL-3 and EPO, and there are STAT-binding sites present in the CIS promoter (Matsumoto et al., 1997; Verdier et al., 1998) . In bone marrow derived macrophages from STAT5a (7/7) mice, GM-CSF induced expression of CIS was greatly reduced demonstrating a critical role for STAT5a in its transcriptional regulation (Feldman et al., 1997) . CIS associates with the phosphorylated tyrosine residues of cytokine receptor signaling sub-units and overexpression acts to reduce the growth rate of cells. By regulating expression of CIS, or CIS-related proteins, cells may be able to control the level and duration of STAT activation which may play a critical role in the decision to proliferate or dierentiate. Of course regulation of dierentiation by STATs is unlikely to be limited to the regulation of just one or two genes. In an analysis of IL-3 induced genes the introduction of a dominant-negative STAT5 reduced the expression of cfos, CIS, OSM and pim-1 (Mui et al., 1996) . This is accompanied by a partial inhibition of IL-3 dependent growth. Thus it is likely that the regulation of multiple targets rather than a single`master gene' that de®nes a cells choice to proliferate or dierentiate.
Further players regulating apoptosis have also been demonstrated to be regulated in a STAT-dependent manner. In the STAT5a de®cient macrophages, described above, GM-CSF induced expression of the bcl-2 like gene, A1, is greatly reduced (Feldman et al., 1997) . Overexpression of A1 in the IL-3 dependent 32Dc13 cell line leads to a reduction of cell death upon cytokine withdrawal (Lin et al., 1996) . Interestingly, ectopic expression of A1 permits the accumulation of dierentiated myeloid cells both before and after IL-3 withdrawal. Thus regulation of A1 expression may not only protect cells against apoptosis but also play a role in deciding the dierentiation state. In mouse neutrophils, A1 is constitutively expressed and essential for neutrophil survival (Orlofsky et al., 1999; Hamasaki et al., 1998) .
STAT5a/b (7/7) mice suer from fetal anemia and apoptosis of red cell progenitors (Socolovsky et al., 1999) . A principle function of EPO is to rescue committed erythroid progenitors from apoptosis. The null mutant embryos are severely anemic with low numbers of erythroid progenitors which show higher levels of apoptosis and are less responsive to EPO. This is thought to be due to the inability of EPO to activate speci®c STAT5 target genes. One of these was identi®ed as the anti-apoptotic Bcl-xL gene through direct binding to its promoter.
At least in lymphocytes, the cell cycle inhibitor p27 KIP1 appears to be a target of STAT activation (Kaplan et al., 1998) . In STAT6 (7/7) mice the normal proliferative response of lymphocytes to IL-4 is compromised. This appears to be due to dysregulated expression of p27 KIP1 caused by an inability of STAT6 to down-regulate p27 KIP1 expression. As previously noted, the induction of myeloid dierentiation is preceded by a reduction in proliferation. STAT3 is critical in the IL-6 induced growth arrest and dierentiation of M1 leukemic cells . Among the genes regulated by IL-6, the repression of c-myc and c-myb expression are likely to play a crucial role in the process of growth arrest and dierentiation (Homan-Liebermann and Liebermann, 1991; Selvakumaran et al., 1992) . IL-6 was also found to induce the cell cycle inhibitor p19 INK4D in a STAT3 dependent fashion (Narimatsu et al., 1997) . Growth arrest and megakaryocytic dierentiation of CMK cells by TPO has also been reported to be accompanied by the induction of p21 WAF/CIP most likely through STAT5 (Matsumura et al., 1997) . Furthermore, ectopic overexpression of p21 WAF/CIP was sucient to induce megakaryocytic dierentiation of CMK cells dependent on its ability to induce cell cycle arrest. p21 WAF/CIP has also been found to be an immediate early response gene induced during the dierentiation of HL-60 cells along the granulocyte or monocytemacrophage pathway (Jiang et al., 1994) . Fukada et al. (1998) have analysed the role STAT3 plays in G 1 to S phase cell cycle progression induced by the gp130 cytokine receptor sub-unit. The gp130-mediated growth signaling was due to the upregulation of the CDK-activators cyclins D2, D3 and A and the concomitant down-regulation of p21 WAF/CIP and p27 KIP1 . Furthermore, STAT3 was found to rapidly activate the c-myc gene by directly binding to its promoter (Kiuchi et al., 1999) . This regulation is speci®c for STAT3 and, for example, the c-myc promoter is not regulated by STAT5. A recent study has employed a constitutively active STAT5a mutant in the IL-3 dependent BaF3 cell line to analyse the regulation of proliferation and apoptosis (Nosaka et al., 1999) . This mutant STAT5a was constitutively tyrosine phosphorylated and induced expression of Bcl-xL, pim-1, and c-myc in the absence of IL-3. Surprisingly, IL-3 treatment of cytokinedeprived BaF3 cells expressing active STAT5a resulted in apoptosis or dierentiation followed by death. This was preceded by high expression of the growth inhibitory genes such as CIS, JAB and p21 WAF/CIP . Constitutive expression of JAB proved sucient to induce apoptosis while p21 WAF/CIP could induce dierentiation. Furthermore, constitutive expression of pim-1 resulted in IL-3 independent growth of BaF3 cells and pim-1 expression was found to be elevated in factor-independent leukemic cells, such as K562, harboring constitutively active STAT5. These ®ndings suggest that STAT5a can regulate cell fate by varying the intensity and expression of components of the cell cycle machinery as well as anti-apoptotic genes.
Besides genes that play a role in myeloid dierentiation, several genes that encode for important modulators of mature myeloid cells contain STAT binding sides in their promoter regions. The high anity FcgRI (CD64) is activated by G-CSF in human neutrophils by STAT1 and STAT3 binding to the IFN-inducible GRR in the FcgRI promoter (Bovolenta et al., 1996) . Similarly, Intercellular adhesion molecule 1 (ICAM-1) , an important regulator of leukocyte adhesion, is induced by IFNg and IL-6 in a STAT-dependent fashion (Naik et al., 1997; Caldenhoven et al., 1994) . Therefore, STATs are also likely to be of importance for terminally dierentiated myeloid cells.
The role of STATs in dysregulated myelogenesis
As described above, STAT proteins are essential for cytokine-regulated processes such as cellular proliferation, dierentiation as well as survival. However, more recently it has become evident that aberrant activation of STAT proteins is often associated with cellular transformation by various oncoproteins. More importantly, activation of STATs 1, 3 and 5 was reported in several human malignancies, including lymphomas, leukemia's and breast carcinoma (reviewed in Garcia and Jove, 1998) . In this section we will describe the role of activated STATs in myeloid malignancies.
In vitro transformation of myeloid cells by v-Src
Myeloid malignancies are often characterized by arrested maturation and cytokine-independent proliferation of myeloid progenitors. This process can be mimicked in vitro with the myeloblastic 32Dcl3 cellline. Expression of v-Src in these cells completely abrogates IL-3 dependence of these cells and blocks their ability to terminally dierentiate into granulocytes in response to G-CSF (Kruger and Anderson, 1991) . 32Dcl3 cells expressing v-Src contain constitutively active STAT1, STAT3 and STAT5, of which only STAT3 could be co-immunoprecipitated with v-Src (Chaturvedi et al., 1997) . Activation of these STATs by v-Src is critically dependent on the SH2 and SH3 domains of v-Src, and strictly correlates with its ability to cause cytokine-independent growth (Chaturvedi et al., 1997) . Although direct evidence that STAT activation by v-Src contributes to the abrogation of IL-3 dependence is currently lacking, IL-3 induced STAT3 activation was reported to contribute to the proliferation of these cells (Chaturvedi et al., 1998) . Interestingly, c-src rather than JAK2 might be the kinase that activates STAT3 in normal IL-3 stimulated 32Dcl3 cells (Chaturvedi et al., 1998) . More direct evidence that STAT3 activation can contribute to cellular transformation comes from experiments in ®broblast cell lines. In these cells, v-Src expression causes the constitutive activation of STAT3 (Yu et al., 1995; Cao et al., 1996) . Interestingly, experiments using dominant negative STAT3 mutants strongly suggest that STAT3 activation is required for transformation by v-Src (Bromberg et al., 1998; Turkson et al., 1998 Turkson et al., , 1999 . Recently, it was shown that interfering with STAT3 signaling in vivo induces potent anti-tumor activity in mice. Gene therapy by electroinjection of DN-STAT3 into pre-existing B16 melanoma tumors caused inhibition of tumor growth as well as tumor regression (Niu et al., 1999) . Moreover, a synthetic constitutively active (CA) STAT3 mutant can mediate cellular transformation in ®broblasts (Bromberg et al., 1999) . More recently, STAT5 activation by v-Src was also implicated in the transformation of ®broblasts (De Groot et al., 1999) . These results strongly suggest that constitutive activation of STATs in myeloid leukemia model systems are likely to be involved in cellular transformation.
Activation of STATs in chronic-and acute myelogenous Leukemia (CML and AML)
CML can be divided in a stable phase characterized by excessive proliferation and accumulation of myeloid cells in all dierentiation states, such as myelocytes, metamyelocytes and neutrophils, followed by a blastic phase that resembles acute leukemia. CML is caused by the BCR/ABL chimeric oncogene, a constitutively active tyrosine kinase which is generated from the Philadelphia chromosome translocation (t(9;22) (q34;q11)) (Rowley, 1973) . There are two distinct forms of Bcr/Abl, the consequence of dierent breakpoints on chromosome 22. p210 is the hallmark of CML, while p190 is found mostly in acute lymphoblastic leukemia (ALL). Although it is clear that the tyrosine kinase activity of BCR/ABL is essential for transformation (Daley et al., 1987; Daley and Baltimore, 1988) , the actual mechanism by which BCR/ABL transforms cells remains largely unknown. Interestingly, BCR/ABL constitutively activates several signaling pathways (reviewed in Sattler and Salgia, 1997) that are also used by several cytokines, including those of the IL-5/IL-3/GM-CSF cytokine family (reviewed in De Groot et al., 1998) . These pathways include the RAS-Erk2, the PI3Kinase and the JAK/ STAT pathways. In addition, BCR/ABL activates the phosphatases SHP1 and SHP2, which also play a pivotal role in IL-5/IL-3/GM-CSF signaling.
The ®rst notion that activation of STATs might be of importance to CML came from experiments performed by Carlesso et al. (1996) , who demonstrated constitutive activation of STAT1 and STAT5 in human CML cell lines as well as in cytokine dependent cell lines transformed by Bcr/Abl. Interestingly, the JAK kinases were not constitutively active in any of these cells, suggesting that STAT1 and STAT5 can be directly activated by Bcr/Abl (Carlesso et al., 1996) . Since then, multiple reports have con®rmed the activation of STAT5 (and to a lesser extent STAT1 and 3) in both primary blood cells and cell lines from CML patients as well as cell lines transformed in vitro by Bcr/Abl (Ilaria and Van Etten, 1996; Frank and Varticovski, 1996; Weber-Nordt et al., 1996; Shuai et al., 1996; Chai et al., 1997; Nieborowska-Skorska et al., 1999) . Although some of these reports also observe constitutive JAK activation in Bcr/Abl transformed cells, the failure of dominant-negative JAK mutants to block Bcr/Abl induced STAT5 activation strengthens the notion that Bcr/Abl directly activates STATs (Ilaria and Van Etten, 1996) . Interestingly, although Bcr/Abl expression in myeloid cells frequently results in the induction of IL-3/GM-CSF autocrine loops, blocking antibodies to these cytokines failed to inhibit constitutive STAT5 activation in several CML cell lines (Chai et al., 1997) . Both p210 and p190 were able to activate STATs, although some smaller dierence in ecacy were reported between the two (Ilaria and Van Etten, 1996; Frank and Varticovski, 1996) . Initial Bcr/Abl mutagenesis studies demonstrated that STAT5 activation is strictly dependent on Bcr/Abl kinase activity, and strongly correlates with its ability to confer cytokine independent growth in hematopoietic cells (Shuai et al., 1996) .
Since STAT5 was shown to be necessary for cellular proliferation induced by the IL-5/IL-3/GM-CSF cytokine family (Mui et al., 1996) and overexpression of constitutively active (CA) STAT5 stimulates cell proliferation (Onishi et al., 1998; Nosaka et al., 1999) , it seems conceivable that it might also contribute to cellular transformation by BCR/Abl. Recently, it was indeed shown that dominant negative STAT5 decreases STAT5-dependent transcription as well as growth in soft agar in K562 CML cells (De Groot et al., 1999) . Using a dierent approach, a similar conclusion was drawn by Nieborowska-Skorska et al. (1999) who showed that STAT5 induction by Bcr/Abl is strictly dependent on its SH2 and SH3 domains. An SH2/SH3 mutant Bcr/Abl molecule functions as tyrosine kinase and activates Ras, but fails to induce IL-3 independence in 32D cells or cause leukemia in SCID mice (Nieborowska-Skorska et al., 1999) . Importantly, these features could be rescued by a dominant active mutant of STAT5. Moreover, dominant negative mutants of STAT5 also inhibited IL-3 independence and leukemogenesis by wild-type BcrAbl. Taken together, these results strongly suggest that STAT5 regulated pathways contribute to Bcr/Abl induced leukemogenesis.
The role of STATs in AML is less clear than in CML. AML is characterized by a maturation arrest resulting in the accumulation of undierentiated myeloid cells in bone marrow and peripheral blood (Pinto et al., 1998; Lowenberg and Touw, 1993) . Growth and dierentiation of AML cells can still be in¯uenced by various cytokines, which in some patients are produced by the leukemic cells themselves. In contrast to CML, multiple dierent chromosomal translocations can be found. The ®rst evidence for a potential role of activated STATs in AML was found by who found constitutive DNA binding of STAT3 (5/5) and STAT5 (2/5) in leukemic cells in the peripheral blood of ®ve AML patients. These data were extended shortly after by others showing activation of STAT1, STAT3 and STAT5 in primary cells from patients with AML (Aronica et al., 1996; Weber-Nordt et al., 1996; Hayakawa et al., 1998; Xia et al., 1998) . In some AML patients, STAT activity could be further regulated by exogenous cytokines, while others were completely cytokine-insensitive (Xia et al., 1998) . In some AML cells, constitutive STAT3 phosphorylation is dependent on the autocrine/paracrine action of IL-6 produced by these cells (Schuringa et al., 1999) . Activation of MAP kinase however, which is also frequently found in AML cells, did not correlate with STAT activity (Hayakawa et al., 1998) . Further experiments are necessary to examine whether STAT activation plays a broad role in the leukemic properties of AML cells.
The ®rst human tumor bearing a structurally abnormal STAT gene was recently reported (Arnould et al., 1999) . In a patient with acute promyelocytic leukemia (APL), they found that the retinoic receptor alpha (RARA) gene, which is fused to the promyelocytic leukemia (PML) gene in most APLs, was fused with STAT5B. Interestingly, the RARA-STAT5B fusion protein was found in the nucleus of APL cells, where it might well act as a constitutive transcriptional activator. In AML cells containing constitutively active STAT3, a point mutation was identi®ed in STAT3, resulting in a H-Y substitution in the n-terminus (Weber-Nordt et al., 1999) . Whether this mutation is causally involved in STAT3 activation and AML is at present unclear.
STAT target genes and oncogenesis
The results described above suggest the existence of STAT target genes that contribute to the transformed properties of CML and possibly also AML) cells. Since in CML cells, Bcr-Abl often causes resistance to apoptosis as well as cytokine-independent cellular proliferation, it seems conceivable that STAT target genes might be found among these genes involved in regulating cellular survival or cell cycle regulation (Figure 3) .
Cell cycle progression is regulated by a complex molecular machinery of positive and negative regulators (Sherr and Roberts, 1999) . Of these, cyclinD1, a Signaling by the IL-5 receptor is included for comparison positive regulator of G1 phase progression, is thought to play a major role in Bcr/Abl transformed cells. Cyclin D1 expression in Bcr/Abl transformed cells is dependent on the tyrosine kinase activity and the SH2 domain of Bcr/Abl (Afar et al., 1995; Yamada et al., 1996) . Importantly, a transformation-defective SH2 mutant of Bcr/Abl could be rescued by overexpression of cyclinD1, but not cyclinE (Afar et al., 1995) . Similarly, cyclinD1 was shown to be essential for G1 progression in Bcr/Abl transformed cells Williamson et al., 1997) . More recently, it has become clear that cyclinD1 is a direct target gene for STATs. In BaF3 cells, IL-3 induced cyclinD1 expression was shown to be inhibited by DN-STAT5, while CA-STAT5 induced IL-3 independent cyclinD1 promoter activity (Matsumura et al., 1999) . Similarly, CA-STAT3 also induces cyclinD1 expression (Bromberg et al., 1999) . Indeed, the cyclin D1 promoter was shown to contain binding sites for STAT3 and STAT5 (Matsumura et al., 1999; Bromberg et al., 1999) . Moreover, we have recently shown that in Bcr/Abl transformed cells, cyclinD1 promoter activity is upregulated by a STAT5-dependent mechanism (de Groot et al., submitted).
Increasing evidence suggests that Bcr/Abl induced cyclinD1 expression is linked to up-regulation of c-myc expression. The cyclinD1-cdk4 kinase complex was shown to phosphorylate pRb in Bcr/Abl transformed cells, resulting in the release of active E2F1 (Williamson et al., 1997) . E2F1 can enhance c-myc expression by direct binding to the c-myc promoter (Stewart et al., 1995) . Since the transformation de®cient Bcr/Abl SH2 mutant that can be rescued by cyclinD1 expression can also be complemented by c-myc (Afar et al., 1994) and DN-c-myc blocks transformation by Bcr/Abl (Afar et al., 1994; Sawyers et al., 1992) , these results suggest the importance of the linear pathway Bcr/Abl ± STAT5 ± cyclinD1 ± c-myc. However, recent evidence also suggests that STATs might directly regulate c-myc expression (Kiuchi et al., 1999) .
CML cells generally exhibit enhanced resistance to apoptosis induced by chemotherapeutic drugs. Similarly, expression of Bcr/Abl in IL-3 dependent cells renders these cells resistant to apoptosis induced by cytokine-deprivation (Daley and Baltimore, 1988) . Proteins of the Bcl-2 family are important regulators of the decision between survival or death in response to an apoptotic stimulus (Reed, 1998) . Recent studies have shown that Bcr/Abl expression causes an upregulation of the level of Bcl-xL, an anti-apoptotic Bcl-2 family member, while the expression of bcl-2 was down-regulated (Amarante-Mendes et al., 1998a,b; Belhoussine et al., 1999) . Similar observations were made in the CML cell line K562 (Amarante-Mendes et al., 1998b) . Interestingly, enhanced Bcl-xL expression was recently reported to be crucial for the malignant progression of multiple myeloma by preventing apoptosis . This upregulation of Bcl-xL was shown to be mediated directly by constitutively activated STAT3 . Similarly, CA-STAT3 can induce Bcl-xL expression (Bromberg et al., 1999) . A number of reports show that Bcl-xL expression can also be regulated directly by STAT5. IL-3 induced Bcl-xL expression can be blocked by DN-STAT5, resulting in enhanced apoptosis in BaF3 cells (Dumon et al., 1999) . DA-STAT5 can induce Bcl-xL expression in the absence of cytokine stimulation (Nosaka et al., 1999) . Finally, in STAT5A/5B knock-out mice, Epo-induced Bcl-xL expression is completely lost (Socolovsky et al., 1999) . Our recent results suggest that this process might also contribute to apoptosis resistance in CML, since we have found that Bcr/Abl induced Bcl-xL promoter activity is dependent on activated STAT5 (de Groot et al., submitted). Although these results strongly suggest that up-regulation of Bcl-xL is important in CML, other anti-apoptotic proteins might also be dysregulated in CML. In this aspect it is noteworthy to mention that expression of the anti-apoptotic serine kinase pim-1 is also induced by DA-STAT5 in a cytokine-independent manner (Nosaka et al., 1999 ).
Future prospects
As described above, STATs are thought to play an important role in the regulation of normal myeloid dierentiation. In addition, accumulating evidence suggests that activated STATs might also play a pivotal role in the pathogenesis of human leukemia's, such as AML and CML. The identi®cation of critical target genes regulating hematopoietic proliferation and dierentiation will uncover the mechanisms by which the same cells become transformed. The recent availability of dominant active STAT molecules will be of great help in determining the genes which are involved in these diverse biological processes. Similarly, conditional STAT knockouts will provide valuable information on the precise function of distinct STATs in dierent cell types. Another challenging ®eld will be the development of molecules with STAT-inhibiting properties, which might prove of great help in understanding and even controlling diseases such as AML and CML.
